Market Overview:
The global drospirenone and ethinyl estradiol tablets market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of hormonal imbalance in women, rising awareness about oral contraceptives, and technological advancements in the field of contraception. Based on type, the global drospirenone and ethinyl estradiol tablets market is segmented into 3mg/0.03mg and 3mg/0.02mg tablets. The 3mg/0.03 mg tablet segment is expected to account for a larger share of the market during the forecast period owing to its higher dosage strength as compared to 3 mg/0 .02 mg tablet segment. Based on application, the global drospirenone and ethinyl estradiol tablets market is segmented into pharmacy, hospital, clinic, online store segments respectively).
Product Definition:
Drospirenone and Ethinyl Estradiol Tablets is a combined oral contraceptive pill. It contains the hormones drospirenone and ethinyl estradiol. Drospirenone and Ethinyl Estradiol Tablets are used to prevent pregnancy.
3mg/0.03mg:
3mg/0.03mg is a low oral dose combination of an estrogen and a progesterone, which are the basic hormones for female hormone function. The 3:0 mixture is used in birth control pills as well as postmenopausal women to prevent bone thinning and osteoporosis ( weaken bones).
3mg/0.02mg:
3mg/0.02mg is a form of oral contraceptive drug combination used in birth control pills. It is also known as third-generation oral contraceptive or tri-ethinyl estradiol and norethindrone acetate, USP. The drug was first approved by the U.
Application Insights:
Drospirenone and ethinyl estradiol tablets are available in various formulations such as generic, combination, progestin-only, and others. The other application segment includes the use of drospirenone and ethinyl estradiol tablets for weight loss products. The weight loss product segment is expected to witness significant growth over the forecast period owing to increasing awareness about calorie intake reduction among consumers globally. Drospirenone is a synthetic progestogen which prevents ovulation in women; therefore preventing fertilization leading to birth control pills.
The combination formulation of drospirenone with EE contains two active ingredients that act together to prevent pregnancy: oginine (a synthetic derivative of caffeine) which acts as an anti-androgenic compound while EE works by inhibiting sperm motility & causes changes in the cervical mucus rendering it unsuitable for sperm survival and implantation.
Regional Analysis:
North America dominated the market in 2017. The presence of a large number of manufacturers and suppliers coupled with high awareness levels regarding Drospirenone/Ethinyl Estradiol Tablets is expected to drive the regional market over the forecast period. In addition, increasing demand for birth control pills among women is also expected to propel growth over the next eight years.
Asia Pacific region is anticipated to witness significant growth during the forecast period owing to an increase in healthcare expenditure and birth rate in countries such as China, India, Indonesia, Pakistan & Bangladesh which will boost product demand during the forecast period.
In terms of revenue share, Europe accounted for 24% share in 2017 owing mainly high sales tax on oral contraceptive drugs (28%).
Growth Factors:
- Increasing awareness about contraception and birth control methods
- Rising number of women in the workforce
- Growing prevalence of sexually transmitted infections (STIs)
- Increasing demand for oral contraceptives from developing countries
- Technological advancements in oral contraceptive delivery systems
Scope Of The Report
Report Attributes
Report Details
Report Title
Drospirenone and Ethinyl Estradiol Tablets Market Research Report
By Type
3mg/0.03mg, 3mg/0.02mg
By Application
Pharmacy, Hospital, Clinic, Online Store
By Companies
Bayer AG, Camber Pharmaceuticals, Morningside Pharmaceuticals, Lupin Pharmaceuticals, Xiromed, Sun Pharmaceutical, Hetero Drugs, Jubilant Cadista, Mylan, Glenmark Pharmaceuticals, Bayer AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Drospirenone and Ethinyl Estradiol Tablets Market Report Segments:
The global Drospirenone and Ethinyl Estradiol Tablets market is segmented on the basis of:
Types
3mg/0.03mg, 3mg/0.02mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacy, Hospital, Clinic, Online Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Camber Pharmaceuticals
- Morningside Pharmaceuticals
- Lupin Pharmaceuticals
- Xiromed
- Sun Pharmaceutical
- Hetero Drugs
- Jubilant Cadista
- Mylan
- Glenmark Pharmaceuticals
- Bayer AG
Highlights of The Drospirenone and Ethinyl Estradiol Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 3mg/0.03mg
- 3mg/0.02mg
- By Application:
- Pharmacy
- Hospital
- Clinic
- Online Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drospirenone and Ethinyl Estradiol Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drospirenone is a progestin and ethinyl estradiol is an estrogen. These medications are used together to prevent pregnancy. Drospirenone works by preventing ovulation (the release of an egg from the ovary) while ethinyl estradiol helps to maintain the uterine lining.
Some of the major companies in the drospirenone and ethinyl estradiol tablets market are Bayer AG, Camber Pharmaceuticals, Morningside Pharmaceuticals, Lupin Pharmaceuticals, Xiromed, Sun Pharmaceutical, Hetero Drugs, Jubilant Cadista, Mylan, Glenmark Pharmaceuticals, Bayer AG.
The drospirenone and ethinyl estradiol tablets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drospirenone and Ethinyl Estradiol Tablets Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Drospirenone and Ethinyl Estradiol Tablets Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Drospirenone and Ethinyl Estradiol Tablets Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Drospirenone and Ethinyl Estradiol Tablets Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Drospirenone and Ethinyl Estradiol Tablets Market Size & Forecast, 2018-2028 4.5.1 Drospirenone and Ethinyl Estradiol Tablets Market Size and Y-o-Y Growth 4.5.2 Drospirenone and Ethinyl Estradiol Tablets Market Absolute $ Opportunity
Chapter 5 Global Drospirenone and Ethinyl Estradiol Tablets Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
5.2.1 3mg/0.03mg
5.2.2 3mg/0.02mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drospirenone and Ethinyl Estradiol Tablets Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
6.2.1 Pharmacy
6.2.2 Hospital
6.2.3 Clinic
6.2.4 Online Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drospirenone and Ethinyl Estradiol Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drospirenone and Ethinyl Estradiol Tablets Analysis and Forecast
9.1 Introduction
9.2 North America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
9.6.1 3mg/0.03mg
9.6.2 3mg/0.02mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
9.10.1 Pharmacy
9.10.2 Hospital
9.10.3 Clinic
9.10.4 Online Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drospirenone and Ethinyl Estradiol Tablets Analysis and Forecast
10.1 Introduction
10.2 Europe Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
10.6.1 3mg/0.03mg
10.6.2 3mg/0.02mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
10.10.1 Pharmacy
10.10.2 Hospital
10.10.3 Clinic
10.10.4 Online Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drospirenone and Ethinyl Estradiol Tablets Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
11.6.1 3mg/0.03mg
11.6.2 3mg/0.02mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
11.10.1 Pharmacy
11.10.2 Hospital
11.10.3 Clinic
11.10.4 Online Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drospirenone and Ethinyl Estradiol Tablets Analysis and Forecast
12.1 Introduction
12.2 Latin America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
12.6.1 3mg/0.03mg
12.6.2 3mg/0.02mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
12.10.1 Pharmacy
12.10.2 Hospital
12.10.3 Clinic
12.10.4 Online Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drospirenone and Ethinyl Estradiol Tablets Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Type
13.6.1 3mg/0.03mg
13.6.2 3mg/0.02mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drospirenone and Ethinyl Estradiol Tablets Market Size Forecast by Applications
13.10.1 Pharmacy
13.10.2 Hospital
13.10.3 Clinic
13.10.4 Online Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drospirenone and Ethinyl Estradiol Tablets Market: Competitive Dashboard
14.2 Global Drospirenone and Ethinyl Estradiol Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer AG
14.3.2 Camber Pharmaceuticals
14.3.3 Morningside Pharmaceuticals
14.3.4 Lupin Pharmaceuticals
14.3.5 Xiromed
14.3.6 Sun Pharmaceutical
14.3.7 Hetero Drugs
14.3.8 Jubilant Cadista
14.3.9 Mylan
14.3.10 Glenmark Pharmaceuticals
14.3.11 Bayer AG